Manlius, NY, United States of America

Pallaiah Thammana




Average Co-Inventor Count = 7.5

ph-index = 2

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 2003-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Pallaiah Thammana: Innovator in Recombinant Protein Production

Introduction

Pallaiah Thammana is a notable inventor based in Manlius, NY (US). He has made significant contributions to the field of biotechnology, particularly in the production of recombinant proteins. With a total of 7 patents, Thammana's work has advanced the understanding and application of mammalian cell systems in producing therapeutic proteins.

Latest Patents

Thammana's latest patents include innovative compositions and methods for producing a composition. One of his key inventions provides for mammalian cells capable of producing recombinant CTLA4-Ig and its variants. This invention also encompasses compositions comprising CTLA4-Ig and formulations thereof. Furthermore, it outlines methods for mass-producing CTLA4-Ig from mammalian cells and for purifying the CTLA4-Ig, enhancing the efficiency of therapeutic protein production.

Career Highlights

Throughout his career, Pallaiah Thammana has worked with prominent companies, including Bristol-Myers Squibb Company. His expertise in recombinant protein production has positioned him as a valuable asset in the biotechnology sector.

Collaborations

Thammana has collaborated with notable professionals in his field, including Kirk J. Leister and Eugene J. Schaefer. These collaborations have contributed to the advancement of his research and innovations.

Conclusion

Pallaiah Thammana's contributions to the field of biotechnology through his patents and collaborations highlight his role as an innovator in recombinant protein production. His work continues to influence the development of therapeutic proteins, showcasing the importance of innovation in this critical area of research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…